GERN logo

GERN
Geron Corp.

21,381
Mkt Cap
$1.01B
Volume
13.66M
52W High
$2.01
52W Low
$1.04
PE Ratio
-12.28
GERN Fundamentals
Price
$1.58
Prev Close
$1.60
Open
$1.62
50D MA
$1.52
Beta
1.17
Avg. Volume
18.96M
EPS (Annual)
-$0.1252
P/B
4.48
Rev/Employee
$712,717.05
$771.77
Loading...
Loading...
News
all
press releases
Almitas Capital LLC Buys Shares of 946,323 Geron Corporation $GERN
Almitas Capital LLC bought a new position in Geron Corporation (NASDAQ:GERN - Free Report) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission...
MarketBeat·3h ago
News Placeholder
More News
News Placeholder
Geron (NASDAQ:GERN) Stock Price Passes Above Two Hundred Day Moving Average - Here's What Happened
Geron (NASDAQ:GERN) Stock Price Passes Above 200-Day Moving Average - Here's What Happened...
MarketBeat·1d ago
News Placeholder
Geron (NASDAQ:GERN) Trading Up 10.9% - Here's What Happened
Geron (NASDAQ:GERN) Trading Up 10.9% - Here's What Happened...
MarketBeat·9d ago
News Placeholder
Can Reblozyl Stabilize BMY's Top Line Amid Legacy Drugs Decline?
Reblozyl tops $2.3B in annualized sales, emerging as a key drug for Bristol Myers as demand rises in MDS-related anemia and new study data support expansion.
Zacks·10d ago
News Placeholder
Geron Corporation $GERN Shares Sold by Segall Bryant & Hamill LLC
Segall Bryant & Hamill LLC lowered its position in Geron Corporation (NASDAQ:GERN - Free Report) by 25.8% in the third quarter, according to its most recent Form 13F filing with the Securities...
MarketBeat·10d ago
News Placeholder
Investors Eye Explosive Growth in Anti-Aging Therapies as Market Targets $420B Milestone
Investors Eye Explosive Growth in Anti-Aging Therapies as Market Targets $420B Milestone Investors Eye Explosive Growth in Anti-Aging Therapies as Market Targets $420B Milestone PR Newswire NEW YORK...
PR Newswire·12d ago
News Placeholder
HC Wainwright Issues Optimistic Outlook for Geron Earnings
Geron Corporation (NASDAQ:GERN - Free Report) - Research analysts at HC Wainwright boosted their Q1 2026 EPS estimates for Geron in a report released on Wednesday, February 25th. HC Wainwright...
MarketBeat·16d ago
News Placeholder
HC Wainwright Weighs in on Geron's Q2 Earnings (NASDAQ:GERN)
Geron Corporation (NASDAQ:GERN - Free Report) - Analysts at HC Wainwright issued their Q2 2026 EPS estimates for Geron in a research note issued to investors on Wednesday, February 25th. HC...
MarketBeat·17d ago
News Placeholder
Geron (NASDAQ:GERN) Shares Gap Down - Time to Sell?
Geron (NASDAQ:GERN) Shares Gap Down - Here's What Happened...
MarketBeat·18d ago
News Placeholder
Geron (NASDAQ:GERN) Announces Earnings Results
Geron (NASDAQ:GERN - Get Free Report) issued its quarterly earnings data on Wednesday. The biopharmaceutical company reported ($0.03) EPS for the quarter, hitting the consensus estimate of ($0.03...
MarketBeat·18d ago
<
1
2
...
>

Latest GERN News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.